Sign Up For Life Science Leader Magazine

THE CURRENT ISSUE

  • What Kind Of Environment Do You Create As A Leader?
    What Kind Of Environment Do You Create As A Leader?

    A recent client of mine — we’ll call him Eli — was transitioning into a new role in a new company. After several months on the job, establishing and immersing himself in the new culture, he asked me to collect some feedback on his colleagues’ opinions of him.

  • Precision Oncology: Big Data And Analytics Come To Cancer Care
    Precision Oncology: Big Data And Analytics Come To Cancer Care

    Cancer care is creating a new era of precision oncology. Profiling the molecular alterations in a patient’s tumor can identify changes that correlate with likely response or resistance to particular therapies. This type of molecular profiling also can lead to more precise treatment, replacing historical “one-size-fits-all” approaches.

  • Overlooking GMP Biopharm Education/Training Can Cost You – Big Time
    Overlooking GMP Biopharm Education/Training Can Cost You – Big Time

    Today, GMP-compliant manufacturing of biopharmaceutical drugs and vaccines is still only partially automated and not at the level of other manufacturing industries. Critical process steps such as sampling, sterile connection, or column packing are carried out manually by operators, which can negatively impact process reproducibility, product quality, and — in the worst case — even patient safety.

  • Janssen Pharmaceuticals R&D Adopts A Venture Capital Innovation Model
    Janssen Pharmaceuticals R&D Adopts A Venture Capital Innovation Model

    Faced with diminishing returns on R&D investments, large pharmaceutical companies are searching for innovative ways to successfully identify, develop, and market products with financial viability. Yet small discovery companies and biotechs continue to outpace large pharma in the approval of NMEs (new molecular entities).

  • Quality Agreements In Clinical Development: A Road Map Toward A Successful Partnership
    Quality Agreements In Clinical Development: A Road Map Toward A Successful Partnership

    With clinical research continuing the trend of outsourcing more clinical trial activities to clinical service providers such as CROs or other vendors, it has become critical for sponsors to ensure that the activities they have outsourced are performed in accordance with the sponsor’s quality expectations. Because of shortened development timelines, often after a rigorous selection process, the clinical service provider immediately starts work on the project without the benefit of both parties discussing their expectations of quality.

  • From Publish-Or-Perish To Product Creation – Putting Your Research Into Action
    From Publish-Or-Perish To Product Creation – Putting Your Research Into Action

    Neoantigenics is a biotechnology company that was based on unique IP that was discovered at the University of Virginia (UVA). John Herr, Ph.D., chief scientific officer, is the principal investigator and a tenured professor in the Departments of Cell Biology and Biomedical Engineering at UVA.

  • Salvaging Value In Divestitures
    Salvaging Value In Divestitures

    The unfortunate truth is that most business divestitures are characterized by value destruction from inception to close. That’s PwC’s conclusion about divestitures according to Glenn Hunzinger, a partner at PwC Transaction Services. “Selling a business is probably the hardest thing a company can do,” he says.

More Magazine Articles....

LIFE SCIENCE TRAINING INSTITUTE

More From LSTI
Newsletter Signup
Newsletter Signup
Get the latest industry news, insights, and analysis delivered to your inbox.
Join your peers
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.

VIEW THE DIGITAL EDITION

 UPCOMING EVENTS

Monitoring Informed Consent (IC): Frequently Asked Questions

February 2, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Regulatory Affairs for Biologics – A Compliance Primer

February 4, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Surviving a FDA GCP Inspection – Preparation Techniques for Success

February 5, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

FDA Guidance on Social Media: Questions Answered and Unanswered

February 10, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Strategic Clinical Project Management: Principles and Practical Applications

February 11, 2015
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate
See All Events